Ovarian cancer accounts for more deaths than any other gynecologic cancer. In 2025, the World Health Organization estimates the disease ...
Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role ...
Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...
Evert says her ovarian cancer has returned for a third time, forcing the tennis legend to step away from Wimbledon and other ...
The results further support the potential of ZW191 to address limitations of currently available and investigational FRα-targeted therapies and broaden treatment opportunities for patients with ...
Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, ...
Chris Evert, famed tennis player, has shared that her ovarian cancer has returned for the second time. She was first ...
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. LONDON — GSK said Tuesday it would buy the ...
Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted ...
20d
Tailored menopause treatments, another naloxone approval and benefits of healthy lifestyle changes
Experts have released new menopause guidelines, and researchers say healthy lifestyle changes are best for long-term health. Here are today's health headlines.
PcW is sizing the menopause market wrong—not by accident, but by design. The $15 billion figure is a floor, not a ceiling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results